Beijing Tongrentang Co Ltd (600085) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Beijing Tongrentang Co., Ltd engages in the production and sale of traditional Chinese medicine preparations in China and internationally. The company offers various product dosage forms, such as pills, powders, medicated wines, capsules, oral liquids, and drop pills.

Total Revenue Chart for Beijing Tongrentang Co Ltd

Beijing Tongrentang Co Ltd (600085) revenue for FY2025 was CNY 17.3B, a -7.2% change from FY2024. Beijing Tongrentang Co Ltd's revenue grew from CNY 462.9M in 1994 to CNY 17.3B in 2025 (3628.0% over 31 years). Earnings per share grew from CNY 0.11 in 2000 to CNY 1.04 in 2022 (822.7%). Revenue compound annual growth rate: 5-year CAGR of 6.1%, 10-year CAGR of 4.7%, 20-year CAGR of 9.9%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.